CT
BMY icon

Caldwell Trust’s Bristol-Myers Squibb BMY Stock Holding History

Caldwell Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
30,189
-2,960
-9% -$170K 0.14% 126
2026
Q1 		$2.01M Sell
33,149
-435
-1% -$25.4K 0.18% 108
2025
Q4 		$1.81M Sell
33,584
-1,587
-5% -$76.3K 0.16% 110
2025
Q3 		$1.59M Sell
35,171
-1,458
-4% -$68.1K 0.15% 127
2025
Q2 		$1.7M Sell
36,629
-1,209
-3% -$59.3K 0.17% 117
2025
Q1 		$2.31M Buy
37,838
+135
+0.4% +$7.87K 0.25% 90
2024
Q4 		$2.13M Sell
37,703
-1,264
-3% -$70.6K 0.22% 94
2024
Q3 		$2.02M Sell
38,967
-1,431
-4% -$67.1K 0.21% 99
2024
Q2 		$1.68M Sell
40,398
-740
-2% -$33.1K 0.19% 107
2024
Q1 		$2.23M Sell
41,138
-2,212
-5% -$113K 0.26% 84
2023
Q4 		$2.22M Sell
43,350
-2,843
-6% -$149K 0.28% 79
2023
Q3 		$2.68M Sell
46,193
-2,841
-6% -$174K 0.37% 64
2023
Q2 		$3.14M Sell
49,034
-1,182
-2% -$79.3K 0.41% 55
2023
Q1 		$3.48M Sell
50,216
-1,158
-2% -$81.7K 0.48% 49
2022
Q4 		$3.7M Buy
51,374
+382
+0.7% +$28.8K 0.52% 51
2022
Q3 		$3.63M Sell
50,992
-1,209
-2% -$87.7K 0.54% 46
2022
Q2 		$4.02M Buy
52,201
+3,532
+7% +$269K 0.55% 47
2022
Q1 		$3.55M Sell
48,669
-578
-1% -$38.8K 0.42% 58
2021
Q4 		$3.07M Sell
49,247
-950
-2% -$55.7K 0.35% 65
2021
Q3 		$2.97M Sell
50,197
-2,962
-6% -$195K 0.38% 63
2021
Q2 		$3.55M Sell
53,159
-1,306
-2% -$85.2K 0.46% 52
2021
Q1 		$3.44M Sell
54,465
-562
-1% -$35K 0.48% 50
2020
Q4 		$3.41M Sell
55,027
-6,406
-10% -$394K 0.52% 50
2020
Q3 		$3.7M Sell
61,433
-4,315
-7% -$260K 0.61% 46
2020
Q2 		$3.87M Buy
65,748
+12
+0% +$718 0.65% 45
2020
Q1 		$3.66M Sell
65,736
-2,120
-3% -$130K 0.69% 44
2019
Q4 		$4.36M Buy
+67,856
New +$3.89M 0.67% 48

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caldwell Trust's BMY Position: Q2 2026 in Review

Caldwell Trust reduced its Bristol-Myers Squibb (BMY) stake by 8.9% in Q2 2026, selling an estimated $170K and leaving 30,189 shares worth $1.74M. The position accounts for 0.14% of the portfolio, ranked #126.

Caldwell Trust first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.36M in Q4 2019. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Caldwell Trust held 30,189 shares of Bristol-Myers Squibb worth $1.74M as of Q2 2026.
  • Caldwell Trust sold 2,960 Bristol-Myers Squibb shares in Q2 2026, an estimated $170K.
  • Bristol-Myers Squibb made up 0.14% of Caldwell Trust's portfolio in Q2 2026, its #126 holding.
  • Caldwell Trust first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Caldwell Trust's Bristol-Myers Squibb position peaked at $4.36M in Q4 2019.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.